Two Sigma Securities’s Adamas Pharmaceuticals ADMS Stock Holding History

Two Sigma Securities’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,915	Closed	-$59K	–	2213
2021 Q3	$59K	Buy	+11,915	New	+$57.9K	﹤0.01%	1368

Two Sigma Securities's ADMS Position: Q4 2021 in Review

Two Sigma Securities sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 11,915 shares — an estimated $59K sold.

Two Sigma Securities first reported a position in ADMS in Q3 2021 and held it in 1 quarter. The position peaked at $59K in Q3 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

Two Sigma Securities reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Two Sigma Securities sold 11,915 Adamas Pharmaceuticals shares in Q4 2021, an estimated $59K.
Two Sigma Securities first reported a position in Adamas Pharmaceuticals in Q3 2021 and held it in 1 quarter.
Two Sigma Securities's Adamas Pharmaceuticals position peaked at $59K in Q3 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Two Sigma Securities's 13F filing for Q4 2021, filed 14 Feb 2022.